Skip to content

Evaluation of postprandial salinity concentration in blood: a randomized, double-blind, placebo-controlled, crossover trial

Evaluation of postprandial salinity concentration in blood: a randomized, double-blind, placebo-controlled, crossover trial - Evaluation of postprandial salinity concentration in blood

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000030166
Enrollment
16
Registered
2017-11-29
Start date
2017-11-29
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Japanese adult people

Interventions

I. Salt excretion supplement II. Placebo supplement * The intervention sequence is I-II, and each food is single ingestion. * Take 3 capsules before eating the prescribed diet (2 rice balls: the in

Sponsors

ORTHOMEDICO Inc.
Lead Sponsor
Medical Corporation Seishinkai, Takara Clinic
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Healthy Japanese adult people 2. Subjects who are judged as eligible to participate in the study by the principal investigator 3. Select the participants as equal as possible based on sodium concentration in blood at screening

Exclusion criteria

Exclusion criteria: 1. At least one previous medical history or under the treatment of malignant tumor, heart failure or myocardial infarction 2. Currently under the treatment for either cardiac arrhythmia, hepatic disorder, renal disorder, cerebrovascular disorder, rheumatism, diabetes mellitus, dyslipidemia, hypertension, or other chronic diseases 3. Subjects who use or take "Foods for Specified Health Uses", "Foods with Functional Claims", or other functional food/beverage in daily 4. Currently taking medicines (include herbal medicines) and supplements 5. Subjects who are allergic to medicines and/or the test food related products 6. Subjects who are pregnant, breast-feeding, and planning to become pregnant 7. Subjects who have been enrolled in other clinical trials within the last three months before the agreement to participate in this trial 8. Subjects who are judged as ineligible to participate in the study by the principal investigator

Design outcomes

Primary

MeasureTime frame
Area under curve (AUC) of sodium concentration (Na) in blood between before meal and 120 minutes after meal * Take blood samples before eating the prescribed diet and at 30, 60, 90, and 120 minutes after meal (total 5 times).

Secondary

MeasureTime frame
1-1. Sodium (Na) concentration in blood 1-2. Iron (Fe) concentration in blood 1-3. Potassium (K) concentration in blood 1-4. Chloride (Cl) concentration in blood 1-5. Inorganic phosphate (IP) concentration in blood 2. systolic blood pressure, diastolic blood pressure, and pulse rate *1 Take blood samples before eating the prescribed diet and at 30, 60, 90, and 120 minutes after meal (total 5 times). For 1-1, the blood sodium concentration is evaluated before meal and at 30, 60, 90, and 120 minutes after meal. For 1-2 ~ 1-5, the area under curve (AUC) is evaluated between before meal and 120 minutes after meal. *2 Physical examination is conducted before eating the prescribed diet and at 30, 60, 90, and 120 minutes after meal (total 5 times).

Countries

Japan

Contacts

Public ContactNaoko SUZUKI

ORTHOMEDICO Inc. R&D Department

nao@orthomedico.jp03-3818-0610

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026